Latest Biotech Startup Funding Rounds

Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.

This page showsSector: Biotech
Rounds
603
All time
Disclosed funding
$28.7B
480 disclosed amounts
Median round
$17M
Of disclosed amounts
603 rounds
Funding rounds
CompanyAmountRoundSectorCountryInvestorsAnnounced
Allos AIAI · United StatesCompany profile

Causal AI and pharmaceutical development services for reformulating complex drugs and directing laboratory studies.

Causal AI and pharmaceutical development services for reformulating complex drugs and directing laboratory studies.

$5MSeedBiotech, AIUnited StatesInvestors
Trailhead BiosystemsBiotech · United StatesCompany profile

Develops human cells with defined molecular and functional properties for drug discovery and regenerative medicine

Develops human cells with defined molecular and functional properties for drug discovery and regenerative medicine

$20MGrowthBiotechUnited StatesInvestors
Oricell TherapeuticsBiotech · ChinaCompany profile

Develops next-generation cell therapies for oncology and immunology

Develops next-generation cell therapies for oncology and immunology

$70MSeries C1Series C+BiotechChinaInvestors
Juvena TherapeuticsBiotech · United StatesCompany profile

Develops regenerative biologics to restore tissue function

Develops regenerative biologics to restore tissue function

$33.5MSeries BBiotechUnited StatesInvestors
OutSeeBiotech · United KingdomCompany profile

Develops AI-based predictive genomics approach to target discovery

Develops AI-based predictive genomics approach to target discovery

£2.5MSeedBiotechUnited KingdomInvestors
Kinaset TherapeuticsBiotech · United StatesCompany profile

Develops inhaled therapies for severe respiratory diseases

Develops inhaled therapies for severe respiratory diseases

$103MSeries BBiotechUnited StatesInvestors
MEDIPOSTBiotech · United StatesCompany profile

MEDIPOST develops stem-cell therapies derived from donated umbilical cord blood.

MEDIPOST develops stem-cell therapies derived from donated umbilical cord blood.

$140MUndisclosedBiotechUnited StatesInvestors
bit.bioBiotech · United KingdomCompany profile

Creates functional, human-relevant cells and models for research, drug discovery, and development

Creates functional, human-relevant cells and models for research, drug discovery, and development

$50MSeries CSeries C+BiotechUnited KingdomInvestors
AirNexis TherapeuticsBiotech · United StatesCompany profile

AirNexis Therapeutics develops medicines for pulmonary diseases, led by the investigational COPD candidate AN01.

AirNexis Therapeutics develops medicines for pulmonary diseases, led by the investigational COPD candidate AN01.

$200MSeries ABiotechUnited StatesInvestors
VizgenBiotech · United StatesCompany profile

Builds technologies for spatial biology and multi-omics innovation

Builds technologies for spatial biology and multi-omics innovation

$48MSeries ABiotechUnited StatesInvestors

Active investors in this selection

All investors →

Ranked by rounds participated in · All time

  1. 1
    RA Capital Management

    Delix Therapeutics, Alethio Therapeutics, Estuary Biotherapeutics

    27rounds
    6led
  2. 2
    Eli Lilly and Company

    Oyster Therapeutics, BigHat Biosciences, Circle Pharma, Inc.

    16rounds
    0led
  3. 3
    Janus Henderson Investors

    Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics

    16rounds
    1led
  4. 4
    ARCH Venture Partners

    Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences

    16rounds
    1led
  5. 5
    OrbiMed

    Dren Bio, Star Therapeutics, Leal Therapeutics

    12rounds
    1led

Latest digests

Archive →

Explore published rounds while the next edition is being prepared.

Browse rounds by topic